Vertebroplasty spells
relief for back pain
By: James Brice
Residual questions about
vertebroplasty's safety and efficacy were put to
rest at the 2005 ECR. Dr. Giovanni C. Anselmetti,
medical director of the Interventional Radiology
Service of Candiolo in Torino, Italy, announced
results of a seven-center trial that included
1580 vertebroplasty patients.
Of that total, 74% of the patients underwent
vertebroplasty for pain caused by osteoporotic
vertebral fractures, and 9% had fractures
associated with neoplastic disease. The
remainder had either angioma or injury from
trauma.
Interventions involved fluoroscopy-guided
percutaneous injection of cement to seal
fractures in up to six spinal vertebrae. Routine
follow-up CT evaluated possible leakage.
The trial demonstrated that vertebroplasty
nearly always delivers spinal pain relief.
Anselmetti found that 92% of patients
experienced substantial pain abatement within 48
hours of the procedure:
- 98% of patients with osteoporosis reported
a reduction of at least two points in a
self-reported scale describing their level of
pain;
- 70% of cancer patients said their back pain
was reduced substantially; and
- all of the angioma and trauma patients
reported major pain relief.
No percutaneous intervention caused major
neurologic damage, but 12 patients were treated
for asymptomatic cement pulmonary emboli, and
439, or 39%, of the cases involved venous and
disc leakage. In six cases, the
interventionalists addressed a subcutaneous
hematoma during follow-up, and local steroid
injection successfully relieved 10 patients of
residual pain.
During the same session, Dr. Johannes
Hierholzer, a professor of interventional
radiology at the University of Potsdam in
Germany, presented data assuring fellow
interventionalists that vertebroplasty rarely
precedes secondary fractures.
Based on the experience of 237 patients at
his clinic, Hierholzer found a 13% rate of
secondary fractures in the year following
surgery. One-third of those fractures were
detected in the three months after
vertebroplasty. Another 41% occurred between
three and six months after the intervention.
Potsdam's secondary fracture rate is about
double the composite 7% rate reported by various
physicians in the medical literature, Hierholzer
said, and it is somewhat higher than the 9%
rates reported by the Interventional Radiology
Service of Candiolo. He found a Texas service
that has a 23% rate of secondary fractures.
Hierholzer could not identify a discernible
pattern for secondary fractures along the spine
or a relationship with the repair site where
secondary fractures may appear. The highest
incidences occurred at the T11 and T4 vertebrae,
but Hierholzer could not find any reason for a
concentration of fractures at those sites.
Fractures were slightly more likely to occur
above the repair site than below.
Hierholzer sees no need for prophylactic
vertebroplasty to anticipate fracture, even for
so-called sandwich vertebrae located between
vertebroplasty sites. He found no evidence to
support prophylactic treatment of such sites,
although some experts in this field advocate
that approach.